OmniAb, Inc. - Common Stock (OABI)
Industrials › Services-Commercial Physical & Biological Research
Price History
Feb 9, 2026 — Apr 1, 2026Investment Snapshot
- P/B of 0.85 — trading below book value
- Piotroski F-Score 1/9 — signs of financial weakness
- Loss-making — negative ROE of -25.1%
- Revenue declining 29% annually
OmniAb, Inc. - Common Stock (OABI) is a Industrials company operating in Services-Commercial Physical & Biological Research, listed on the NASDAQ , with a market capitalisation of $227 million . Key value metrics: P/B ratio 0.85, Piotroski F-Score 1 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 4 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
OmniAb, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, OABI shows a weak Piotroski F-Score of 1/9, a signal of deteriorating financial health, and negative return on equity of -25.1% (sector average: 5.5%), and minimal leverage with a debt-to-equity ratio of 0.13.
StockPik's composite Value Score for OABI is 45/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
OABI shows revenue declining at 29% year-over-year, with earnings declining at 4%.